New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2019, WHO consolidated guidelines on drug-resistant tuberculosis treatment
View latest version (2019)Bibliographic Info
GuidelineGuidelines for the programmatic management of drug-resistant tuberculosis - 2011 update
Year of Publication2011
Issuing InstitutionWorld Health Organization
Recommendation
Status
Retired
Recommended in favor
Conditional
Certainty of evidence
Very low
In the treatment of patients with multidrug-resistant tuberculosis (MDR-TB), an intensive phase of 8 months is suggested for most patients, and the duration may be modified according to the patient’s response to therapy